Comprehensive Analysis of Phagocytosis-Related Regulators to Aid Prognostic Prediction and Immunotherapy in Patients with Low-Grade Glioma

<div>Exploring potential immune checkpoints in different PRs-risk groups. (a) Significant immune checkpoint expression in different risk groups. (b) The difference in CTLA4, CD279, and CD274 expressions in S100A11, CNN3, POFUT1, SAMD4B, NPAS2, and SDHC groups.</div>

Disease Markers

fig11

Figure 11

Figure 11: Comprehensive Analysis of Phagocytosis-Related Regulators to Aid Prognostic Prediction and Immunotherapy in Patients with Low-Grade Glioma 

Figure 11 | Comprehensive Analysis of Phagocytosis-Related Regulators to Aid Prognostic Prediction and Immunotherapy in Patients with Low-Grade Glioma 